Opportunity Assessment
Validate hospital and patient demand across priority Southeast Asian markets. Covers hospital CIO interviews, regulatory mapping, and a market-by-market Go/Defer/Kill recommendation.
Learn more →
Our POV · 2026
Southeast Asia healthtech market entry strategy
Southeast Asia is one of the world's most significant healthtech opportunities – combining 680 million people, rapidly growing private healthcare infrastructure, post-pandemic telehealth adoption, and significant healthcare workforce shortages that create demand for technology-enabled healthcare delivery. International healthtech companies across telemedicine, diagnostic AI, hospital information systems, digital pharmacy, and health insurance technology are all evaluating Southeast Asia market entry. GreyRadius helps healthtech companies navigate the regulatory and cultural diversity of Southeast Asian healthcare markets.
Why now? Healthcare system investment across Southeast Asia is at a multi-decade high – Vietnam's hospital construction programme, Indonesia's JKN national health insurance expansion, Thailand's medical tourism infrastructure, and Philippines' universal healthcare implementation are all creating specific healthtech procurement opportunities in 2024–2028.
$40B+
Southeast Asia digital health market by 2027
Growing at 22% annually as telemedicine adoption, hospital digitalisation, and national health insurance expansion all accelerate.
30+
Primary interviews per Southeast Asia healthtech mandate
Hospital CIOs, clinical department heads, and health regulators across ASEAN – every engagement grounded in direct primary research.
8 weeks
Market entry strategy delivery
AI-augmented multi-market hospital demand mapping delivers Southeast Asia healthtech market entry strategies efficiently.
Market Intelligence
What the data says.
Southeast Asia digital health market is projected to reach $40B by 2027 – growing at 22% annually as telemedicine adoption, hospital digitalisation, and national health insurance expansion all accelerate.
Indonesia's JKN national health insurance with 240 million members is creating the largest single healthcare data ecosystem in Southeast Asia – creating healthtech integration opportunities.
Vietnam's 1,200 new hospital bed target annually is creating significant hospital information system and medical equipment procurement.
Thailand's medical tourism leadership is driving premium healthtech adoption – hospitals competing for international patients are investing in technology-enabled quality and patient experience.
Market Reality
What makes this market hard.
- Regulatory classification of digital health products varies across ASEAN – each country has different medical device rules, telemedicine regulations, and health data privacy requirements.
- Hospital IT infrastructure quality varies dramatically – Singapore's hospitals operate on par with leading global systems while rural Indonesian and Philippine hospitals have basic IT infrastructure.
- Healthcare professional shortage affects healthtech adoption – countries with the greatest healthtech need often have the least capacity to implement and manage new technology.
- Health data privacy regulation is evolving rapidly – PDPA in Thailand, Indonesia's Personal Data Protection Law, and Vietnam's data localisation requirements all affect health data architecture.
Our Work
What we solve for clients.
If you recognise your situation below, we can help.
Southeast Asia healthtech market prioritisation
You need to identify which ASEAN markets offer the best combination of healthtech demand, regulatory access, and hospital infrastructure for your product.
Country-specific regulatory classification and pathway
You need to understand medical device registration, telemedicine licensing, and health data requirements in each target market.
Hospital system GTM strategy for Southeast Asia
You need a go-to-market plan covering private hospital chain acquisition, government hospital tender strategy, and clinical champion development.
Southeast Asia healthtech partner identification
You need hospital group technology buyers, clinical validation partners, and health insurance integration partners.
Raising capital for Southeast Asia healthtech
You need a pitch book grounded in ASEAN health market demand data.
Government health programme access
You need to identify national health insurance and government digitalisation programme opportunities.
Our Services
How we engage.
Every engagement is grounded in primary research and delivers a measurable outcome.
Feasibility & TEV
Full financial and operational feasibility for Southeast Asia healthtech investment. Covers adoption modelling across markets, regulatory cost, and investor-ready projections.
Learn more →Market Entry Execution
End-to-end Southeast Asia healthtech market entry. Regulatory pathways, hospital chain GTM, clinical champion development, and first-deployment per market.
Learn more →GTM Execution-as-a-Service
Embedded Southeast Asia healthtech GTM team. Hospital outreach, clinical champion pipeline, and first-revenue tracking.
Learn more →Pitchbook & Fundraising
Investor-ready pitch books for Southeast Asia healthtech. ASEAN-health-market-validated demand and investor identification.
Learn more →AI Consulting
AI use-case identification – from local language clinical documentation to AI diagnostics adapted for Southeast Asian disease burden.
Learn more →Why GreyRadius.
Primary research-led
80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Expert-led, AI-enabled delivery
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
Outcomes, not reports
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Case Studies
Mandates we've run.
HealthTech · Market Entry
HealthTech platform market entry into the GCC
Ministry interviewsRegulatory reviewPartner ecosystem
View all case studies →
HealthTech · GTM
GTM for a remote-patient-monitoring SaaS in South Asia
Clinic pipelineFirst contractsMRR target
View all case studies →
HealthTech · Assessment
Opportunity assessment for a chronic-disease app in Southeast Asia
Patient interviewsMarket sizedRevenue model
View all case studies →
FAQ
Common questions.
Which Southeast Asian markets does GreyRadius prioritise for healthtech?+
Indonesia and Vietnam for volume, Thailand and Singapore for premium and export-quality deployments.
Does GreyRadius work with consumer digital health or also with enterprise hospital technology?+
Both.
How long does a Southeast Asia healthtech entry engagement take?+
Typically 8–12 weeks for multi-market research.
Can GreyRadius identify hospital chain technology buyers across ASEAN?+
Yes.
Stay informed
Market intelligence for HealthTech leaders.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Ready to enter this market?
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Gulf, Southeast Asia, South Asia.
Book a call